Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Waldencast Plc (WALD)

Waldencast Plc (WALD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 225,841
  • Shares Outstanding, K 122,076
  • Annual Sales, $ 273,870 K
  • Annual Income, $ -42,440 K
  • EBIT $ 0 M
  • EBITDA $ -3 M
  • 60-Month Beta -0.43
  • Price/Sales 0.86
  • Price/Cash Flow 17.64
  • Price/Book 0.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7701 +7.34%
on 12/15/25
3.2200 -40.99%
on 11/20/25
+0.0100 (+0.53%)
since 11/14/25
3-Month
1.6400 +15.85%
on 11/05/25
3.2200 -40.99%
on 11/20/25
+0.1500 (+8.57%)
since 09/15/25
52-Week
1.4801 +28.37%
on 09/02/25
4.1000 -53.66%
on 01/27/25
-1.9900 (-51.16%)
since 12/13/24

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc ("Waldencast" or the "Company") (NASDAQ: WALD).  Such investors are advised...

WALD : 1.9000 (+2.70%)
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update

Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue Contrasted performance for Milk Makeup with Q2 2025 net revenue growth driven by U.S. channel expansion...

WALD : 1.9000 (+2.70%)
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data...

WALD : 1.9000 (+2.70%)
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it had sold...

WALD : 1.9000 (+2.70%)
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

LONDON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, provided additional details for its upcoming earnings release...

WALD : 1.9000 (+2.70%)
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), the fastest growing professional skincare brand in the U.S. in 2024*, proudly unveils its latest innovation rooted in clinical...

WALD : 1.9000 (+2.70%)
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand

LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration (“FDA”) has...

WALD : 1.9000 (+2.70%)
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation

Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand’s Addressable Market in the U.S. Milk Makeup Delivers Strong Retail Sales...

WALD : 1.9000 (+2.70%)
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Acquisition strengthens Obagi Medical’s product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and...

WALD : 1.9000 (+2.70%)
Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast

Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio

WALD : 1.9000 (+2.70%)

Business Summary

Waldencast plc. provide multi-brand beauty and wellness platform which involved in developing, acquiring, accelerating and scaling the next generation of conscious, purpose-driven brands. Waldencast plc., formerly known as Waldencast Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 2.1010
2nd Resistance Point 2.0089
1st Resistance Point 1.9544
Last Price 1.9000
1st Support Level 1.8078
2nd Support Level 1.7157
3rd Support Level 1.6612

See More

52-Week High 4.1000
Fibonacci 61.8% 3.0992
Fibonacci 50% 2.7901
Fibonacci 38.2% 2.4809
Last Price 1.9000
52-Week Low 1.4801

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar